Quantum Biopharma (QNTM) Shares Outstanding (Diluted Average) (2018 - 2026)
Quantum Biopharma recorded quarterly Shares Outstanding (Diluted Average) of $3.1 million in Q1 2026, down 6.87% quarter-over-quarter from $3.3 million in Q4 2025, and down 13.31% year-over-year from $3.5 million in Q1 2025.
Quantum Biopharma's Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 13.31% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 13.31% YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) came in at $3.1 million for Q1 2026 at Quantum Biopharma, down from $3.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $39998.8 billion in Q1 2022 to a low of $130000.0 in Q2 2024.
- A 5-year average of $11220.3 billion and a median of $7.1 million in 2025 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) tumbled 100.0% in 2023 and jumped 5076.92% in 2025, its largest moves.
- Quantum Biopharma's Shares Outstanding (Diluted Average) stood at $38888.2 billion in 2022, then plunged by 100.0% to $27.2 million in 2023, then tumbled by 59.29% to $11.1 million in 2024, then slumped by 70.29% to $3.3 million in 2025, then dropped by 6.87% to $3.1 million in 2026.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $3.1 million, $3.3 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 7.49 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Mar 31, 2025 | 3.53 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 3.43 Mn |
| Sep 30, 2023 | 27.17 Mn |
| Jun 30, 2023 | 390,000.00 |
| Mar 31, 2023 | 38,962.42 Bn |
| Sep 30, 2022 | 38,888.15 Bn |
| Jun 30, 2022 | 39,234.86 Bn |
| Mar 31, 2022 | 39,998.79 Bn |
| Dec 31, 2021 | 34.95 Mn |
| Sep 30, 2021 | 36,296.05 Bn |
| Jun 30, 2021 | 35,991.92 Bn |
| Mar 31, 2021 | 26,898.89 Bn |
| Dec 31, 2020 | 12.04 Mn |
| Dec 31, 2019 | 5.35 Mn |
| Dec 31, 2018 | 4.47 Mn |